Shanghai Record Pharmaceuticals Co., Ltd.

Shanghai Record Pharmaceuticals co.,Ltd. was established in April 2003. It is a high-tech enterprise with strong R&D capabilities, focusing on the research and development of intermediates, special fine chemical products in electronics and materials, as well as the commercialization of production processes for various types of intermediates. Record's own factory is located in the Lishu Industrial Park in Jixi City, Heilongjiang Province, covering an area of 160 acres. In May 2023, the first phase of the workshop was successfully put into production and obtained ISO certifications, CNAS certification, and has been awarded provincial-level green factory and national-level specialized and innovative "little giant" enterprise titles. On October 27, 2025, the company published a paper titled "N-nitrosamine-mediated direct deamination functionalization" in the internationally recognized, interdisciplinary scientific journal "Nature," which has attracted widespread attention in the scientific community. Record's products are marketed across China and various regions including Japan, America and India, becoming a major supplier of intermediates for well-known pharmaceutical companies both domestically and internationally, while establishing good cooperative relationships with many chemical enterprises, foreign businesses, and traders in the industry. The company adheres to the philosophy of "market-oriented and R&D-focused," creating greater value for customers through innovative process concepts.